# A Safety and Immunogenicity Study of IVACFLU-A/H5N1

> **NCT02612909** · PHASE2,PHASE3 · COMPLETED · sponsor: **Institute of Vaccines and Medical Biologicals, Vietnam** · enrollment: 930 (actual)

## Conditions studied

- Avian Influenza

## Interventions

- **BIOLOGICAL:** IVACFLU-A/H5N1 vaccine
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT02612909
- **Lead sponsor:** Institute of Vaccines and Medical Biologicals, Vietnam
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-07
- **Primary completion:** 2017-08-29
- **Final completion:** 2017-08-30
- **Target enrollment:** 930 (ACTUAL)
- **Last updated:** 2019-05-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02612909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02612909, "A Safety and Immunogenicity Study of IVACFLU-A/H5N1". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02612909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*